Children and young adults with kidney failure due to sickle cell disease (SCD) wait longer for a kidney transplant and have significantly higher mortality when compared to children and young adults with kidney failure not ...
Nov 6, 2023
0
0
Patients with sickle cell disease may soon have two new treatments to try.
Oct 30, 2023
0
1
Born with a deadly blood disease, Clint and Alissa Finlayson's adopted daughters—Ada, nine, and Lily, 12—are the first patients on the West Coast to receive a new gene therapy offered by UCSF Benioff Children's Hospital ...
Oct 28, 2023
0
16
Investigators have identified how the immune system can regulate organ rejection in mice, findings which may prove useful for improving transplant tolerance in humans, according to a recent study published in the Journal ...
Oct 25, 2023
0
23
Infections with cytomegalovirus (CMV) are extremely common and often pose no major threat to the vast majority of people. They can however be deadly for people whose immune system is weakened, for example, after bone marrow ...
Oct 17, 2023
0
27
Giving living donor liver transplant recipients an infusion of immune cells derived from their donor a week before transplantation is feasible, safe—and may lead to recipients being successfully weaned off immunosuppressant ...
Oct 11, 2023
0
69
New research led by a St. Michael's Hospital scientist reveals how platelets can inhibit inflammation and immune responses. The discovery, published in the journal Research, constitutes a fundamental re-understanding of platelets ...
Oct 6, 2023
0
46
New research has identified a novel immunotherapy for acute myeloid leukemia. The study, published in Nature Cancer, describes a T-cell receptor that recognizes a mutation shared between a subgroup of patients with the disease. ...
Oct 2, 2023
0
101
Drew Weissman's decades of research into mRNA technology paved the way for COVID-19 vaccines, finally earning a Nobel prize for the physician-scientist.
Oct 2, 2023
0
33
Acute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival rate of just 65 to 70%, according to the American Cancer Society. While immunotherapies like monoclonal ...
Sep 30, 2023
0
21
